Gene Therapy

Stay updated on Gene Therapy trends and industry impact. Healthcare Brew provides the latest news and professional analysis on Gene Therapy's role in Biotech & Emerging Modalities and Pharma.

A vial containing the active ingredient of the product Elevidys for the treatment of Duchenne muscular dystrophy is labeled at the Roche Diagnostics GmbH plant.
Pharma

Duchenne community mourns patient death, but largely stands behind Elevidys gene therapy

A 16-year-old’s death has ignited a debate around gene therapy and led to a pause of European trials.

Caroline Catherman
exterior view of Mass General Brigham
Pharma

Gene and Cell Therapy Institute seeks to fight rare diseases

The institute, based out of Mass General Brigham, is trying to get new treatments to patients faster.

Cassie McGrath

Navigate the healthcare industry

Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.

By subscribing, you accept our Terms & Privacy Policy.

A mobile phone scrolling a newsletter issue of Healthcare Brew